<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">651658</article-id><article-id pub-id-type="doi">10.31857/S0869813924030015</article-id><article-id pub-id-type="edn">CQBTSK</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Meta-Analysis of Experimental Studies of the Effect of Melatonin Monotherapy on Body Weight Gain and Eating Behavior in Rats on Different Diets</article-title><trans-title-group xml:lang="ru"><trans-title>Метаанализ экспериментальных исследований влияния монотерапии мелатонином на прирост массы тела и пищевое поведение крыс при различных диетах</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuzmenko</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Кузьменко</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nat.kuzmencko2011@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsyrlin</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Цырлин</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nat.kuzmencko2011@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pliss</surname><given-names>M. G.</given-names></name><name xml:lang="ru"><surname>Плисс</surname><given-names>М. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nat.kuzmencko2011@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Galagudza</surname><given-names>М. М.</given-names></name><name xml:lang="ru"><surname>Галагудза</surname><given-names>М. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nat.kuzmencko2011@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Almazov National Medical Research Centre</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр им. В. А. Алмазова Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">First Pavlov State Medical University of St. Petersburg</institution></aff><aff><institution xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2024</year></pub-date><volume>110</volume><issue>3</issue><issue-title xml:lang="ru"/><fpage>299</fpage><lpage>325</lpage><history><date date-type="received" iso-8601-date="2025-02-01"><day>01</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/651658">https://journals.eco-vector.com/0869-8139/article/view/651658</self-uri><abstract xml:lang="en"><p>In an earlier meta-analysis, we showed that long-term melatonin administration minimizes diet-induced changes in lipid profiles. The purpose of our present work was to use a meta-analysis to investigate the effect of melatonin monotherapy on body weight gain (BWG) and eating behavior in rats depending on diet. To this end, we conducted a meta-analysis of 43 publications examining the effects of melatonin monotherapy on BWG, leptin levels, food and water intake in rats fed a standard diet (37 publications), as well as high-fructose diets (5 publications) and fats (9 publications). Our findings suggest that although melatonin reduced the level of triglycerides, total cholesterol and leptin in rats fed high-fructose and high-fat diets but not those fed a standard diet, melatonin treatment prevented BWG in rats on either diet. Increasing the dose of melatonin did not enhance the effect of therapy with any of the diets studied. We did not obtain convincing evidence that the effect of melatonin depends on the initial body weight and age of rats. On a standard diet, melatonin has been found to reduce food and water intake. Melatonin did not reduce BWG with a standard diet when administered intraperitoneally. Our research suggests that melatonin may be beneficial for diet-induced metabolic disorders by improving lipid profiles and preventing BWG. However, a decrease in appetite and BWG when taking melatonin may also be associated with negative side effects of the drug, which requires further research.</p></abstract><trans-abstract xml:lang="ru"><p>В раннее проведенном метаанализе мы показали, что длительное введение мелатонина минимизирует изменения в липидном профиле, вызванные диетой. Целью настоящей работы являлось с помощью метаанализа исследовать эффект монотерапии мелатонином на прирост массы тела (ПМТ) и пищевое поведение у крыс в зависимости от диеты. С этой целью мы провели метаанализ 43 публикаций, исследующих влияние монотерапии мелатонином на ПМТ, уровень лептина, потребление еды и воды у крыс, содержащихся на стандартной диете (37 публикаций), а также на диетах с повышенным содержанием фруктозы (5 публикаций) и жиров (9 публикаций). По итогам наших исследований, хотя мелатонин снижал уровень триглицеридов, общего холестерина и лептина у крыс, содержащихся на диетах с добавлением фруктозы и жиров, но не на стандартной диете, терапия мелатонином препятствовала набору массы тела крыс при любой диете. Увеличение дозы мелатонина не усиливало эффекта терапии ни при одной из исследованных диет. Мы не получили убедительных доказательств зависимости эффекта мелатонина от исходной массы тела и возраста крыс. Было установлено, что на стандартной диете мелатонин уменьшает потребление пищи и воды. Мелатонин не снижал ПМТ при стандартной диете, если вводился внутрибрюшинно. По итогам наших исследований, мелатонин может быть полезен при метаболических нарушениях, вызванных диетой, поскольку улучшает показатели липидного профиля и препятствует набору массы тела. Однако снижение аппетита и ПМТ при приеме мелатонина может быть связано и с отрицательными побочными эффектами препарата, что нуждается в дальнейших исследованиях.</p></trans-abstract><kwd-group xml:lang="en"><kwd>melatonin</kwd><kwd>body weight gain</kwd><kwd>leptin</kwd><kwd>diet</kwd><kwd>appetite</kwd><kwd>fructose</kwd><kwd>fat</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мелатонин</kwd><kwd>прирост массы тела</kwd><kwd>лептин</kwd><kwd>диета</kwd><kwd>аппетит</kwd><kwd>фруктоза</kwd><kwd>жир</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Правительство РФ</institution></institution-wrap><institution-wrap><institution xml:lang="en">Government of the Russian Federation</institution></institution-wrap></funding-source><award-id>056–00119–22–00</award-id></award-group><funding-statement xml:lang="ru">Данная работа финансировалась за счет средств бюджета Государственного задания № 056–00119–22–00.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Acuña-Castroviejo D, Escames G, Venegas C, Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX, Reiter RJ (2014) Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 71 (16): 2997–3025. https://doi.org/10.1007/s00018–014–1579–2</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Dardente H, Wyse CA, Birnie MJ, Dupré SM, Loudon AS, Lincoln GA, Hazlerigg DG (2010) A molecular switch for photoperiod responsiveness in mammals. Curr Biol 20 (24): 2193– 2198. https://doi.org/10.1016/j.cub.2010.10.048</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Ebling FJ (2014) On the value of seasonal mammals for identifying mechanisms underlying the control of food intake and body weight. Horm Behav 66 (1): 56–65. https://doi.org/10.1016/j.yhbeh.2014.03.009</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ostrowska Z, Kos-Kudla B, Marek B, Kajdaniuk D (2003) Influence of lighting conditions on daily rhythm of bone metabolism in rats and possible involvement of melatonin and other hormones in this process. Endocr Regul 37(3): 163–174. https://www.sav.sk/journals/endo/full/2003/2003_03d.pdf</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ahmed HH, Mannaa F, Elmegeed GA, Doss SH (2005) Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin–induced cardiotoxicity. Bioorg Med Chem 13 (5): 1847–1857. https://doi.org/10.1016/j.bmc.2004.10.066</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Benova T, Viczenczova C, Radosinska J, Bacova B, Knezl V, Dosenko V, Weismann P, Zeman M, Navarova J, Tribulova N (2013) Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethal arrhythmias. Can J Physiol Pharmacol 91 (8): 633–639. https://doi.org/10.1139/cjpp–2012–0393</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Baltaci AK, Mogulkoc R, Kul A, Bediz CS, Ugur A (2004) Opposite effects of zinc and melatonin on thyroid hormones in rats. Toxicology 195 (1): 69–75. https://doi.org/10.1016/j.tox.2003.09.001</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ozturk G, Coşkun S, Erbaş D, Hasanoglu E (2000) The effect of melatonin on liver superoxide dismutase activity, serum nitrate and thyroid hormone levels. Jpn J Physiol 50 (1): 149– 153. https://doi.org/10.2170/jjphysiol.50</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Виноградова ИА (2009) Влияние препаратов «мелатонин» и «эпиталон» на возрастную динамику тиреотропной активности гипофиза и функции щитовидной железы в разных световых режимах. Успехи геронтол 22 (4): 631–638. [Vinogradova IA (2009) Effect of preparations melatonin and epitalon on the age-related dynamics of thyrotrophic activity of the hypophysis and thyroid gland function in different light regimes. Adv Gerontol 22(4): 631–638. (In Russ)].</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kuzmenko NV, Tsyrlin VA, Pliss MG (2023) Meta-analysis of experimental studies of diet-dependent effects of melatonin monotherapy on circulatory levels of triglycerides, cholesterol, glucose and insulin in rats. J Evol Biochem Physiol 59 (1): 213–231. https://doi.org/10.1134/S0022093023010180</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Mohammadi-Sartang M, Ghorbani M, Mazloom Z (2018) Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr 37 (6 Pt A): 1943–1954. https://doi.org/10.1016/j.clnu.2017.11.003</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Loloei S, Sepidarkish M, Heydarian A, Tahvilian N, Khazdouz M, Heshmati J, Pouraram H (2019) The effect of melatonin supplementation on lipid profile and anthropometric indices: A systematic review and meta-analysis of clinical trials. Diabetes Metab Syndr 13 (3): 1901–1910. https://doi.org/10.1016/j.dsx.2019.04.043</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lauritzen ES, Kampmann U, Smedegaard SB, Støy J (2021) Effects of daily administration of melatonin before bedtime on fasting insulin, glucose and insulin sensitivity in healthy adults and patients with metabolic diseases. A systematic review and meta-analysis. Clin Endocrinol (Oxf) 95 (5): 691–701. https://doi.org/10.1111/cen.14576</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Delpino FM, Figueiredo LM, Nunes BP (2021) Effects of melatonin supplementation on diabetes: A systematic review and meta-analysis of randomized clinical trials. Clin Nutr 40 (7): 4595– 4605. https://doi.org/10.1016/j.clnu.2021.06.007</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Delpino FM, Figueiredo LM (2021) Melatonin supplementation and anthropometric indicators of obesity: A systematic review and meta-analysis. Nutrition 91–92: 111399. https://doi.org/10.1016/j.nut.2021.111399</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Guan Q, Wang Z, Cao J, Dong Y, Chen Y (2021) Mechanisms of Melatonin in Obesity: A Review. Int J Mol Sci 23(1): 218. https://doi.org/10.3390/ijms23010218</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Reiter RJ, Tan DX, Korkmaz A, Ma S (2012) Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann Med 44(6): 564–577. https://doi.org/10.3109/07853890.2011.586365</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, Casteilla L, Pénicaud L (2003) Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 144(12): 5347–5352. https://doi.org/10.1210/en.2003–0693</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Wang Y, Liu X, Wang W, Song W, Chen L, Fang Q, Yan X (2013) The expression of inflammatory cytokines on the aorta endothelia are up-regulated in pinealectomized rats. Inflammation 36 (6): 1363–1373. https://doi.org/10.1007/s10753–013–9676–1</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Suriagandhi V, Nachiappan V (2022) Protective Effects of Melatonin against Obesity-Induced by Leptin Resistance. Behav Brain Res 417: 113598. https://doi.org/10.1016/j.bbr.2021.113598</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kim M, Lee SM, Jung J, Kim YJ, Moon KC, Seo JH, Ha TK, Ha E (2020) Pinealectomy increases thermogenesis and decreases lipogenesis. Mol Med Rep 22(5): 4289–4297. https://doi.org/10.3892/mmr.2020.11534</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to Meta–analysis. Wiley. Chichester.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Almabhouh FA, Singh HJ (2018) Adverse effects of leptin on histone-to-protamine transition during spermatogenesis are prevented by melatonin in Sprague-Dawley rats. Andrologia 50(1). https://doi.org/10.1111/and.12814</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Aoyama H, Mori N, Mori W (1987) Anti-glucocorticoid effects of melatonin on adult rats. Acta Pathol Jpn 37(7): 1143–1148. https://doi.org/10.1111/j.1440–1827.1987.tb00431.x</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Bashandy SAE, Ebaid H, Al-Tamimi J, Ahmed-Farid OA, Omara EA, Alhazza IM (2021) Melatonin Alleviated Potassium Dichromate-Induced Oxidative Stress and Reprotoxicity in Male Rats. Biomed Res Int 2021: 3565360. https://doi.org/10.1155/2021/3565360</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Bernasconi PA, Cardoso NP, Reynoso R, Scacchi P, Cardinali DP (2013) Melatonin and diet-induced metabolic syndrome in rats: impact on the hypophysial-testicular axis. Horm Mol Biol Clin Investig 16(2): 101–112. https://doi.org/10.1515/hmbci–2013–0005</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Bojková B, Orendás P, Friedmanová L, Kassayová M, Datelinka I, Ahlersová E, Ahlers I (2008) Prolonged melatonin administration in 6-month-old Sprague-Dawley rats: metabolic alterations. Acta Physiol Hung 95(1): 65–76. https://doi.org/10.1556/APhysiol.95.2008.4</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Cam M, Yavuz O, Guven A, Ercan F, Bukan N, Ustündag N (2003) Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res 35(3): 212–220. https://doi.org/10.1034/j.1600–079x.2003.00082.x</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Canpolat S, Sandal S, Yilmaz B, Yasar A, Kutlu S, Baydas G, Kelestimur H (2001) Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat. Eur J Pharmacol 428(1): 145–148. https://doi.org/10.1016/s0014–2999(01)01230–4</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Canpolat S, Aydin M, Yasar A, Colakoglu N, Yilmaz B, Kelestimur H (2006) Effects of pinealectomy and exogenous melatonin on immunohistochemical ghrelin staining of arcuate nucleus and serum ghrelin leves in the rat. Neurosci Lett 410(2): 132–136. https://doi.org/10.1016/j.neulet.2006.09.071</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Cardinali DP, Bernasconi PA, Reynoso R, Toso CF, Scacchi P (2013) Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats. Int J Mol Sci 14(2): 2502–2514. https://doi.org/10.3390/ijms14022502</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Chuffa LG, Amorim JP, Teixeira GR, Mendes LO, Fioruci BA, Pinheiro PF, Seiva FR, Novelli EL, Mello Júnior W, Martinez M, Martinez FE (2011) Long-term melatonin treatment reduces ovarian mass and enhances tissue antioxidant defenses during ovulation in the rat. Braz J Med Biol Res 44(3): 217–223. https://doi.org/10.1590/s0100–879x2011007500018</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Dantas-Ferreira RF, Raingard H, Dumont S, Schuster-Klein C, Guardiola-Lemaitre B, Pevet P, Challet E (2018) Melatonin potentiates the effects of metformin on glucose metabolism and food intake in high-fat-fed rats. Endocrinol Diabetes Metab 1(4): e00039. https://doi.org/10.1002/edm2.39</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Давыдов ВВ, Медведев ДВ, Шодиев ДР, Некрасова МС (2018) Влияние экзогенного мелатонина на оксидативный статус и состояние перекисного окисления белков у крыс с моделью алиментарного ожирения. Ожирение и метаболизм 15(4): 15–21. [Davydov VV, Medvedev DV, Shodiev DR, Nekrasova MS (2018) Influence of exogenous melatonin on the oxidative status and the state of peroxidation of proteins in a rat model of alimentary obesity. Obesity and Metabolism 15(4): 15–21. (In Russ)]. https://doi.org/10.14341/omet9561]</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Dhanabalan K, Mzezewa S, Huisamen B, Lochner A (2020) Mitochondrial Oxidative Phosphorylation Function and Mitophagy in Ischaemic/Reperfused Hearts from Control and High-Fat Diet Rats: Effects of Long-Term Melatonin Treatment. Cardiovasc Drugs Ther 34(6): 799–811. https://doi.org/10.1007/s10557–020–06997–9</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Djordjevic B, Cvetkovic T, Stoimenov TJ, Despotovic M, Zivanovic S, Basic J, Veljkovic A, Velickov A, Kocic G, Pavlovic D, Sokolovic D (2018) Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes. Eur J Pharmacol 833: 290–297. https://doi.org/10.1016/j.ejphar.2018.06.011</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Ergenc M, Ozacmak HS, Turan I, Ozacmak VH (2022) Melatonin reverses depressive and anxiety like-behaviours induced by diabetes: involvement of oxidative stress, age, rage and S100B levels in the hippocampus and prefrontal cortex of rats. Arch Physiol Biochem 128(2): 402–410. https://doi.org/10.1080/13813455.2019.1684954</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Kadry SM, El-Dakdoky MH, Haggag NZ, Rashed LA, Hassen MT (2018) Melatonin improves the therapeutic role of mesenchymal stem cells in diabetic rats. Toxicol Mech Methods 28(7): 529–538. https://doi.org/10.1080/15376516.2018.1471634</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Kantar Ş, Türközkan N, Bircan FS, Paşaoğlu ÖT (2015) Beneficial effects of melatonin on serum nitric oxide, homocysteine, and ADMA levels in fructose-fed rats. Pharm Biol 53(7): 1035– 1041. https://doi.org/10.3109/13880209.2014.957782</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Kitagawa A, Ohta Y, Ohashi K (2012) Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 52(4): 403–413. https://doi.org/10.1111/j.1600–079X.2011.00955.x</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Korkmaz GG, Uzun H, Cakatay U, Aydin S (2012) Melatonin ameliorates oxidative damage in hyperglycemia-induced liver injury. Clin Invest Med 35(6): E370–E377. https://doi.org/10.25011/cim.v35i6.19209</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Leibowitz A, Peleg E, Sharabi Y, Shabtai Z, Shamiss A, Grossman E (2008) The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome. Am J Hypertens 21(3): 348–351. https://doi.org/10.1038/ajh.2007.60</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Mendes C, Lopes AM, do Amaral FG, Peliciari-Garcia RA, Turati Ade O, Hirabara SM, Scialfa Falcão JH, Cipolla-Neto J (2013) Adaptations of the aging animal to exercise: role of daily supplementation with melatonin. J Pineal Res 55(3): 229–239. https://doi.org/10.1111/jpi.12065</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Mirunalini S, Subramanian P (2005) Temporal oscillations of thyroid hormones in long-term melatonin treated rats. Pharmazie 60(1): 52–56.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Montano ME, Molpeceres V, Mauriz JL, Garzo E, Cruz IB, González P, Barrio JP (2010) Effect of melatonin supplementation on food and water intake in streptozotocin-diabetic and non-diabetic male Wistar rats. Nutr Hosp 25(6): 931–938.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Mori N, Aoyama H, Murase T, Mori W (1989) Anti-hypercholesterolemic effect of melatonin in rats. Acta Pathol Jpn 39(10): 613–618. https://doi.org/10.1111/j.1440–1827.1989.tb02407.x</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Mustonen AM, Nieminen P, Hyvärinen H (2002) Effects of continuous light and melatonin treatment on energy metabolism of the rat. J Endocrinol Invest 25(8): 716–723. https://doi.org/10.1007/BF03345106</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Nasiraei-Moghadam SN, Parivar K, Ahmadiani A, Movahhedin M, Vaez Mahdavi MR (2014) Protective Effect of Melatonin against Inequality-Induced Da mages on Testicular Tissue and Sper m Para meters. Int J Fertil Steril 7(4): 313–322.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Nduhirabandi F, Du Toit EF, Blackhurst D, Marais D, Lochner A (2011) Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 50(2): 171–182. https://doi.org/10.1111/j.1600–079X.2010.00826.x</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Obayemi MJ, Akintayo CO, Oniyide AA, Aturamu A, Badejogbin OC, Atuma CL, Saidi AO, Mahmud H, Olaniyi KS (2021) Protective role of melatonin against adipose-hepatic metabolic comorbidities in experimentally induced obese rat model. PLoS One 16(12): e0260546. https://doi.org/10.1371/journal.pone.0260546</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Paskaloglu K, Sener G, Ayanğolu-Dülger G (2004) Melatonin treatment protects against diabetes-induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur J Pharmacol 499(3): 345–354. https://doi.org/10.1016/j.ejphar.2004.08.002</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Peschke E, Schucht H, Mühlbauer E (2010) Long-term enteral administration of melatonin reduces plasma insulin and increases expression of pineal insulin receptors in both Wistar and type 2-diabetic Goto-Kakizaki rats. J Pineal Res 49(4): 373–381. https://doi.org/10.1111/j.1600–079X.2010.00804.x</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Promyo K, Iqbal F, Chaidee N, Chetsawang B (2020) Aluminum chloride-induced amyloid β accumulation and endoplasmic reticulum stress in rat brain are averted by melatonin. Food Chem Toxicol 146: 111829. https://doi.org/10.1016/j.fct.2020.111829</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Puchalski SS, Green JN, Rasmussen DD (2003) Melatonin effects on metabolism independent of gonad function. Endocrine 21(2): 169–173. https://doi.org/10.1385/ENDO:21:2:169</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Ríos-Lugo MJ, Cano P, Jiménez-Ortega V, Fernández-Mateos MP, Scacchi PA, Cardinali DP, Esquifino AI (2010) Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res 49(4): 342–348. https://doi.org/10.1111/j.1600–079X.2010.00798.x</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM (1999) Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 140(2): 1009–1012. https://doi.org/10.1210/endo.140.2.6674</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Terrón MP, Delgado-Adámez J, Pariente JA, Barriga C, Paredes SD, Rodríguez AB (2013) Melatonin reduces body weight gain and increases nocturnal activity in male Wistar rats. Physiol Behav 118: 8–13. https://doi.org/10.1016/j.physbeh.2013.04.006</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Tung YT, Chiang PC, Chen YL, Chien YW (2020) Effects of Melatonin on Lipid Metabolism and Circulating Irisin in Sprague-Dawley Rats with Diet-Induced Obesity. Molecules 25(15): 3329. https://doi.org/10.3390/molecules25153329</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Wang L, McFadden JW, Yang G, Zhu H, Lian H, Fu T, Sun Y, Gao T, Li M (2021) Effect of melatonin on visceral fat deposition, lipid metabolism and hepatic lipo-metabolic gene expression in male rats. J Anim Physiol Anim Nutr (Berl) 105(4): 787–796. https://doi.org/10.1111/jpn.13497</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, Rasmussen DD (2000) Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 141(2): 487–497. https://doi.org/10.1210/endo.141.2.7311</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Wongchitrat P, Klosen P, Pannengpetch S, Kitidee K, Govitrapong P, Isarankura-Na-Ayudhya C (2017) High-fat diet-induced plasma protein and liver changes in obese rats can be attenuated by melatonin supplementation. Nutr Res 42: 51–63. https://doi.org/10.1016/j.nutres.2017.04.011</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Xu MF, Ho S, Qian ZM, Tang PL (2001) Melatonin protects against cardiac toxicity of doxorubicin in rat. J Pineal Res 31(4): 301–307. https://doi.org/10.1034/j.1600–079x.2001.310403.x</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Zanuto R, Siqueira-Filho MA, Caperuto LC, Bacurau RF, Hirata E, Peliciari-Garcia RA, do Amaral FG, Marçal AC, Ribeiro LM, Camporez JP, Carpinelli AR, Bordin S, Cipolla-Neto J, Carvalho CR (2013) Melatonin improves insulin sensitivity independently of weight loss in old obese rats. J Pineal Res 55(2): 156–165. https://doi.org/10.1111/jpi.12056</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Ghasemi A, Jeddi S, Kashfi K (2021) The laboratory rat: Age and body weight matter. EXCLI J 20: 1431–1445. https://doi.org/10.17179/excli2021–4072</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Laudon M, Nir I, Zisapel N (1988) Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 48(6): 577–583. https://doi.org/10.1159/000125066</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Jenwitheesuk A, Boontem P, Wongchitrat P, Tocharus J, Mukda S, Govitrapong P (2017) Melatonin regulates the aging mouse hippocampal homeostasis via the sirtuin1–FOXO1 pathway. EXCLI J 16: 340–353. https://doi.org/10.17179/excli2016–852</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Cui H, López M, Rahmouni K (2017) The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol 13(6): 338–351. https://doi.org/10.1038/nrendo.2016.222</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Yazıcı D, Sezer H (2017) Insulin Resistance, Obesity and Lipotoxicity. Adv Exp Med Biol 960: 277–304. https://doi.org/10.1007/978–3–319–48382–5_12</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Landecho MF, Tuero C, Valentí V, Bilbao I, de la Higuera M, Frühbeck G (2019) Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. Nutrients 11(11): 2664. https://doi.org/10.3390/nu11112664</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Mustonen AM, Nieminen P, Hyvärinen H (2001) Preliminary evidence that pharmacologic melatonin treatment decreases rat ghrelin levels. Endocrine 16(1): 434–436. https://doi.org/10.1385/ENDO:16:1:43</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Ríos-Lugo MJ, Jiménez-Ortega V, Cano-Barquilla P, Mateos PF, Spinedi EJ, Cardinali DP, Esquifino AI (2015) Melatonin counteracts changes in hypothalamic gene expression of signals regulating feeding behavior in high-fat fed rats. Horm Mol Biol Clin Invest 21(3): 175–183. https://doi.org/10.1515/hmbci–2014–0041</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Viswanathan M, Hissa R, George JC (1986) Effects of short photoperiod and melatonin treatment on thermogenesis in the Syrian hamster. J Pineal Res 3(4): 311–321. https://doi.org/10.1111/j.1600–079x.1986.tb00754.x</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Deveci D, Egginton S (2007) Effects of acute and chronic cooling on cardiorespiratory depression in rodents. J Physiol Sci 57(1): 73–79. https://doi.org/10.2170/physiolsci.RP005906</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Ewida SF, Al-Sharaky DR (2016) Implication of Renal Aquaporin-3 in Fructose-Induced Metabolic Syndrome and Melatonin Protection. J Clin Diagn Res 10(4): CF06–CF11. https://doi.org/10.7860/JCDR/2016/18362.7656</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Gao XY, Deng BH, Li XR, Wang Y, Zhang JX, Hao XY, Zhao JX (2021) Melatonin Regulates Differentiation of Sheep Brown Adipocyte Precursor Cells Via AMP-Activated Protein Kinase. Front Vet Sci 8: 661773. https://doi.org/10.3389/fvets.2021.661773</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Zaminy A, Kashani IR, Barbarestani M, Hedayatpour A, Mahmoudi R, Vardasbi S, Shokrgozar MA (2008) Effects of melatonin on the proliferation and differentiation of rat adipose-derived stem cells. Indian J Plast Surg 41(1): 8–14. https://doi.org/10.4103/0970–0358.41104</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Bassani TB, Gradowski RW, Zaminelli T, Barbiero JK, Santiago RM, Boschen SL, da Cunha C, Lima MM, Andreatini R, Vital MA (2014) Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson’s disease model in rats. Brain Res 1593: 95–105. https://doi.org/10.1016/j.brainres.2014.09.068</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Allagui MS, Feriani A, Saoudi M, Badraoui R, Bouoni Z, Nciri R, Murat JC, Elfeki A (2014) Effects of melatonin on aluminium-induced neurobehavioral and neurochemical changes in aging rats. Food Chem Toxicol 70: 84–93. https://doi.org/10.1016/j.fct.2014.03.043</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47(10): 2336–2348. https://doi.org/10.1023/a:1020107915919</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Siah KT, Wong RK, Ho KY (2014) Melatonin for the treatment of irritable bowel syndrome. World J Gastroenterol 20(10): 2492–2498. https://doi.org/10.3748/wjg.v20.i10.2492</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Da Silva JL, Barbosa LV, Pinzan CF, Nardini V, Brigo IS, Sebastião CA, Elias-Oliveira J, Brazão V, Júnior JCDP, Carlos D, Cardoso CRB (2023) The Microbiota-Dependent Worsening Effects of Melatonin on Gut Inflammation. Microorganisms 11(2): 460. https://doi.org/10.3390/microorganisms11020460</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Khalil SS, Aziz JA, Ismail KA, El-Malkey NF (2021) Comparative protective effects of N-acetylcysteine and melatonin against obesity-induced testicular dysfunction in rats. Can J Physiol Pharmacol 99 (7): 708–719. https://doi.org/10.1139/cjpp–2020–0499</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Jiménez-Ortega V, Cano Barquilla P, Fernández-Mateos P, Cardinali DP, Esquifino AI (2012) Cadmium as an endocrine disruptor: correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin. Free Radic Biol Med 53(12): 2287–2297. https://doi.org/10.1016/j.freeradbiomed.2012.10.533</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Kinson GA, MacDonald NE, Liu CC (1973) The effects of melatonin and serotonin on blood flow fraction and testosterone metabolism in selected organs of the male rat. Can J Physiol Pharmacol 51(5): 313–318. https://doi.org/10.1139/y73–047</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Mercau ME, Calanni JS, Aranda ML, Caldareri LJ, Rosenstein RE, Repetto EM, Cymeryng CB (2019) Melatonin prevents early pituitary dysfunction induced by sucrose-rich diets. J Pineal Res 66(2): e12545. https://doi.org/10.1111/jpi.12545</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Zhou J, Wang D, Luo X, Jia X, Li M, Laudon M, Zhang R, Jia Z (2018) Melatonin Receptor Agonist Piromelatine Ameliorates Impaired Glucose Metabolism in Chronically Stressed Rats Fed a High-Fat Diet. J Pharmacol Exp Ther 364(1): 55–69. https://doi.org/10.1124/jpet.117.243998</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Seabra ML, Bignotto M, Pinto LR Jr, Tufik S (2000) Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res 29(4): 193–200. https://doi.org/10.1034/j.1600–0633.2002.290401.x</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Zetner D, Andersen LP, Rosenberg J (2016) Pharmacokinetics of Alternative Administration Routes of Melatonin: A Systematic Review. Drug Res (Stuttg) 66(4): 169–173. https://doi.org/10.1055/s–0035–1565083</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Ait Abdellah S, Raverot V, Gal C, Guinobert I, Bardot V, Blondeau C, Claustrat B (2023) Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers. Drugs R D 23(3): 257–265. https://doi.org/10.1007/s40268–023–00431–9</mixed-citation></ref></ref-list></back></article>
